Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder

Author/s: 
Mason, B. J.
Date Added: 
November 6, 2022
Journal/Publication: 
Alcohol Research Current Reviews
Publisher: 
National Institutes of Health
Publication Date: 
October 20, 2022
Issue: 
1
Volume: 
42
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
10.35946/arcr.v42.1.11
PMID (1): 
36320345

RPR Commentary

A review of current and potential new medications for treatment of patients with alcohol use disorders. James W. Mold, MD, MPH

Abstract

This article is part of a Festschrift commemorating the 50th anniversary of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Established in 1970, first as part of the National Institute of Mental Health and later as an independent institute of the National Institutes of Health, NIAAA today is the world's largest funding agency for alcohol research. In addition to its own intramural research program, NIAAA supports the entire spectrum of innovative basic, translational, and clinical research to advance the diagnosis, prevention, and treatment of alcohol use disorder and alcohol-related problems. To celebrate the anniversary, NIAAA hosted a 2-day symposium, "Alcohol Across the Lifespan: 50 Years of Evidence-Based Diagnosis, Prevention, and Treatment Research," devoted to key topics within the field of alcohol research. This article is based on Dr. Mason's presentation at the event. NIAAA Director George F. Koob, Ph.D., serves as editor of the Festschrift.

Text Availability

Free full text